%0 Journal Article
%T Hepatic Failure Due to Cholestatic Hepatitis C in an Immunosuppressed Patient Treated With Elbasvir and Grazeprevir
%A Amin H. Nassar
%A Baraa M. Abdul-Jawad
%A David S. Barnes
%J Archive of "ACG Case Reports Journal".
%D 2018
%R 10.14309/crj.2018.6
%X Hepatitis C-induced cholestatic hepatitis is a well-known fatal complication of postorthotropic liver transplantation and prolonged immunosuppression. Recent studies on direct-acting antiviral agents have shown promising results in terms of morbidity and mortality of this condition in postorthotropic liver, heart, and renal transplant patients. However, hepatitis C-induced cholestatic hepatitis remains a highly fatal condition in non-transplant patients. We report the first-ever use of the oral direct-acting antiviral combination, elbasvir and grazeprevir, in the treatment of a non-liver transplant patient with cholestatic hepatitis
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772065/